Heartbeam Financial Statements From 2010 to 2024
BEAT Stock | USD 2.04 0.04 2.00% |
Market Capitalization 52.7 M | Earnings Share (0.72) |
Heartbeam Total Revenue |
|
Check Heartbeam financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heartbeam main balance sheet or income statement drivers, such as Depreciation And Amortization of 14.5 K, Selling And Marketing Expenses of 9.3 M or Total Revenue of 0.0, as well as many exotic indicators such as Price To Sales Ratio of 5.06, Dividend Yield of 0.0 or PTB Ratio of 3.15. Heartbeam financial statements analysis is a perfect complement when working with Heartbeam Valuation or Volatility modules.
Heartbeam | Select Account or Indicator |
Heartbeam Balance Sheet | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Heartbeam Income Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Heartbeam Cash Flow Statement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Ratios | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Heartbeam Valuation Data | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Heartbeam Fundamental Market Drivers
Cash And Short Term Investments | 16.2 M |
Heartbeam Upcoming Events
21st of March 2024 Upcoming Quarterly Report | View | |
9th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
21st of March 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
About Heartbeam Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Heartbeam income statement, its balance sheet, and the statement of cash flows. Heartbeam investors use historical funamental indicators, such as Heartbeam's revenue or net income, to determine how well the company is positioned to perform in the future. Although Heartbeam investors may use each financial statement separately, they are all related. The changes in Heartbeam's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Heartbeam's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Heartbeam Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Heartbeam. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Current Deferred Revenue | (545.10) | (517.84) | |
Total Revenue | 0.00 | 0.00 | |
Cost Of Revenue | 189.6 M | 199 M | |
Stock Based Compensation To Revenue | 0.03 | 0.04 | |
Sales General And Administrative To Revenue | 0.28 | 0.32 | |
Research And Ddevelopement To Revenue | 0.03 | 0.03 | |
Capex To Revenue | (0.06) | (0.06) | |
Revenue Per Share | 12.84 | 9.04 | |
Ebit Per Revenue | 0.19 | 0.20 |
Pair Trading with Heartbeam
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Heartbeam position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heartbeam will appreciate offsetting losses from the drop in the long position's value.Moving together with Heartbeam Stock
0.62 | FORA | Forian Inc Financial Report 10th of May 2024 | PairCorr |
Moving against Heartbeam Stock
0.66 | SRDX | SurModics Earnings Call Next Week | PairCorr |
0.63 | DH | Definitive Healthcare Financial Report 2nd of May 2024 | PairCorr |
0.6 | SIBN | Si Bone Financial Report 6th of May 2024 | PairCorr |
0.54 | ICCM | Icecure Medical Financial Report 27th of May 2024 | PairCorr |
0.54 | LNSR | LENSAR Inc | PairCorr |
The ability to find closely correlated positions to Heartbeam could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Heartbeam when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Heartbeam - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Heartbeam to buy it.
The correlation of Heartbeam is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Heartbeam moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Heartbeam moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Heartbeam can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Heartbeam Correlation against competitors. For more information on how to buy Heartbeam Stock please use our How to Invest in Heartbeam guide.Note that the Heartbeam information on this page should be used as a complementary analysis to other Heartbeam's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Heartbeam Stock analysis
When running Heartbeam's price analysis, check to measure Heartbeam's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heartbeam is operating at the current time. Most of Heartbeam's value examination focuses on studying past and present price action to predict the probability of Heartbeam's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heartbeam's price. Additionally, you may evaluate how the addition of Heartbeam to your portfolios can decrease your overall portfolio volatility.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Heartbeam's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Heartbeam. If investors know Heartbeam will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Heartbeam listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.72) | Return On Assets (0.90) | Return On Equity (1.60) |
The market value of Heartbeam is measured differently than its book value, which is the value of Heartbeam that is recorded on the company's balance sheet. Investors also form their own opinion of Heartbeam's value that differs from its market value or its book value, called intrinsic value, which is Heartbeam's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Heartbeam's market value can be influenced by many factors that don't directly affect Heartbeam's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Heartbeam's value and its price as these two are different measures arrived at by different means. Investors typically determine if Heartbeam is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Heartbeam's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.